Collagen–biomaterial for drug delivery
W Friess - European journal of pharmaceutics and …, 1998 - Elsevier
The use of collagen as a biomaterial is currently undergoing a renaissance in the tissue
engineering field. The biotechnological applications focus on the aspects of cellular growth or …
engineering field. The biotechnological applications focus on the aspects of cellular growth or …
The freezing step in lyophilization: Physico-chemical fundamentals, freezing methods and consequences on process performance and quality attributes of …
JC Kasper, W Friess - European journal of pharmaceutics and …, 2011 - Elsevier
Lyophilization is a common, but cost-intensive, drying process to achieve protein formulations
with long-term stability. In the past, typical process optimization has focused on the drying …
with long-term stability. In the past, typical process optimization has focused on the drying …
Recent advances and further challenges in lyophilization
JC Kasper, G Winter, W Friess - European Journal of Pharmaceutics and …, 2013 - Elsevier
While entering a new century, lyophilization in the pharmaceutical field has been subjected
to ongoing development and steady expansion. This review aims to highlight recent …
to ongoing development and steady expansion. This review aims to highlight recent …
Collagen as a carrier for on-site delivery of antibacterial drugs
Z Ruszczak, W Friess - Advanced drug delivery reviews, 2003 - Elsevier
Due to its biocompatibility and well-established safety profile, collagen represents a
favourable matrix for on-site drug delivery. In this review, we summarize some of the recent …
favourable matrix for on-site drug delivery. In this review, we summarize some of the recent …
Shaken, not stirred: mechanical stress testing of an IgG1 antibody
S Kiese, A Papppenberger, W Friess… - Journal of pharmaceutical …, 2008 - Elsevier
Protein aggregation is known to occur under different stress conditions and displays a wide
variety of morphologies. In this work, the aggregation behavior of a monoclonal antibody (…
variety of morphologies. In this work, the aggregation behavior of a monoclonal antibody (…
Impact of freezing procedure and annealing on the physico-chemical properties and the formation of mannitol hydrate in mannitol–sucrose–NaCl formulations
A Hawe, W Frieß - European journal of pharmaceutics and …, 2006 - Elsevier
The goal was to investigate the impact of NaCl on the physico-chemical properties of
mannitol–sucrose formulations during freezing and drying, with special focus on mannitol hydrate …
mannitol–sucrose formulations during freezing and drying, with special focus on mannitol hydrate …
Protein aggregation: pathways, induction factors and analysis
HC Mahler, W Friess, U Grauschopf, S Kiese - Journal of pharmaceutical …, 2009 - Elsevier
Control and analysis of protein aggregation is an increasing challenge to pharmaceutical
research and development. Due to the nature of protein interactions, protein aggregation may …
research and development. Due to the nature of protein interactions, protein aggregation may …
Particles in therapeutic protein formulations, Part 1: Overview of analytical methods
The presence of particles is a major issue during therapeutic protein formulation development.
Both proteinaceous and nonproteinaceous particles need to be analyzed not only due to …
Both proteinaceous and nonproteinaceous particles need to be analyzed not only due to …
Advancing therapeutic protein discovery and development through comprehensive computational and biophysical characterization
L Gentiluomo, HL Svilenov, D Augustijn… - Molecular …, 2019 - ACS Publications
Therapeutic protein candidates should exhibit favorable properties that render them suitable
to become drugs. Nevertheless, there are no well-established guidelines for the efficient …
to become drugs. Nevertheless, there are no well-established guidelines for the efficient …
[HTML][HTML] N-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteins
Monoclonal antibody and Fc fusion protein drugs are complex heterogeneous mixtures of
numerous different protein variants and modifications. N-glycosylation as one of the most …
numerous different protein variants and modifications. N-glycosylation as one of the most …